Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Sørensen AT[au]:

A robust activity marking system for exploring active neuronal ensembles. Sørensen AT et al. Elife. (2016)

Chemogenetic Modulation of G Protein-Coupled Receptor Signalling in Visual Attention Research. Jørgensen SH et al. Basic Clin Pharmacol Toxicol. (2017)

Noninvasive optical inhibition with a red-shifted microbial rhodopsin. Chuong AS et al. Nat Neurosci. (2014)

Search results

Items: 31

1.

Modulating Dopamine Signaling and Behavior with Chemogenetics: Concepts, Progress, and Challenges.

Runegaard AH, Fitzpatrick CM, Woldbye DPD, Andreasen JT, Sørensen AT, Gether U.

Pharmacol Rev. 2019 Apr;71(2):123-156. doi: 10.1124/pr.117.013995. Review.

PMID:
30814274
2.

Differential effects of chemogenetic inhibition of dopamine and norepinephrine neurons in the mouse 5-choice serial reaction time task.

Fitzpatrick CM, Runegaard AH, Christiansen SH, Hansen NW, Jørgensen SH, McGirr JC, de Diego Ajenjo A, Sørensen AT, Perrier JF, Petersen A, Gether U, Woldbye DPD, Andreasen JT.

Prog Neuropsychopharmacol Biol Psychiatry. 2019 Mar 2;90:264-276. doi: 10.1016/j.pnpbp.2018.12.004. Epub 2018 Dec 6.

PMID:
30529002
3.

Individual Classification of Single Trial EEG Traces to Discriminate Brain responses to Speech with Different Signal-to-Noise Ratios.

Cabrera AF, Petersen EB, Graversen C, Sorensen AT, Lunner T, Rank ML.

Conf Proc IEEE Eng Med Biol Soc. 2018 Jul;2018:987-990. doi: 10.1109/EMBC.2018.8512491.

PMID:
30440556
4.

The C-terminal flanking peptide of neuropeptide Y (NPY) is not essential for seizure-suppressant actions of prepro-NPY overexpression in male rats.

Soud K, Jørgensen SH, Woldbye DPD, Sørensen AT.

J Neurosci Res. 2019 Mar;97(3):362-372. doi: 10.1002/jnr.24350. Epub 2018 Oct 27.

PMID:
30367522
5.

Locomotor- and Reward-Enhancing Effects of Cocaine Are Differentially Regulated by Chemogenetic Stimulation of Gi-Signaling in Dopaminergic Neurons.

Runegaard AH, Sørensen AT, Fitzpatrick CM, Jørgensen SH, Petersen AV, Hansen NW, Weikop P, Andreasen JT, Mikkelsen JD, Perrier JF, Woldbye D, Rickhag M, Wortwein G, Gether U.

eNeuro. 2018 Jun 18;5(3). pii: ENEURO.0345-17.2018. doi: 10.1523/ENEURO.0345-17.2018. eCollection 2018 May-Jun.

6.

Inhibition of a Descending Prefrontal Circuit Prevents Ketamine-Induced Stress Resilience in Females.

Dolzani SD, Baratta MV, Moss JM, Leslie NL, Tilden SG, Sørensen AT, Watkins LR, Lin Y, Maier SF.

eNeuro. 2018 Mar 6;5(1). pii: ENEURO.0025-18.2018. doi: 10.1523/ENEURO.0025-18.2018. eCollection 2018 Jan-Feb.

7.

Npas4 Is a Critical Regulator of Learning-Induced Plasticity at Mossy Fiber-CA3 Synapses during Contextual Memory Formation.

Weng FJ, Garcia RI, Lutzu S, Alviña K, Zhang Y, Dushko M, Ku T, Zemoura K, Rich D, Garcia-Dominguez D, Hung M, Yelhekar TD, Sørensen AT, Xu W, Chung K, Castillo PE, Lin Y.

Neuron. 2018 Mar 7;97(5):1137-1152.e5. doi: 10.1016/j.neuron.2018.01.026. Epub 2018 Feb 8.

8.

Altered Chloride Homeostasis Decreases the Action Potential Threshold and Increases Hyperexcitability in Hippocampal Neurons.

Sørensen AT, Ledri M, Melis M, Nikitidou Ledri L, Andersson M, Kokaia M.

eNeuro. 2018 Jan 23;4(6). pii: ENEURO.0172-17.2017. doi: 10.1523/ENEURO.0172-17.2017. eCollection 2017 Nov-Dec.

9.

Chemogenetic Modulation of G Protein-Coupled Receptor Signalling in Visual Attention Research.

Jørgensen SH, Fitzpatrick CM, Gether U, Woldbye DPD, Sørensen AT.

Basic Clin Pharmacol Toxicol. 2017 Nov;121(5):373-381. doi: 10.1111/bcpt.12819. Epub 2017 Jul 10. Review.

10.

A robust activity marking system for exploring active neuronal ensembles.

Sørensen AT, Cooper YA, Baratta MV, Weng FJ, Zhang Y, Ramamoorthi K, Fropf R, LaVerriere E, Xue J, Young A, Schneider C, Gøtzsche CR, Hemberg M, Yin JC, Maier SF, Lin Y.

Elife. 2016 Sep 23;5. pii: e13918. doi: 10.7554/eLife.13918.

11.

Differential Effect of Neuropeptides on Excitatory Synaptic Transmission in Human Epileptic Hippocampus.

Ledri M, Sørensen AT, Madsen MG, Christiansen SH, Ledri LN, Cifra A, Bengzon J, Lindberg E, Pinborg LH, Jespersen B, Gøtzsche CR, Woldbye DP, Andersson M, Kokaia M.

J Neurosci. 2015 Jul 1;35(26):9622-31. doi: 10.1523/JNEUROSCI.3973-14.2015.

12.

Optogenetics reveal delayed afferent synaptogenesis on grafted human-induced pluripotent stem cell-derived neural progenitors.

Avaliani N, Sørensen AT, Ledri M, Bengzon J, Koch P, Brüstle O, Deisseroth K, Andersson M, Kokaia M.

Stem Cells. 2014 Dec;32(12):3088-98. doi: 10.1002/stem.1823.

13.

Noninvasive optical inhibition with a red-shifted microbial rhodopsin.

Chuong AS, Miri ML, Busskamp V, Matthews GA, Acker LC, Sørensen AT, Young A, Klapoetke NC, Henninger MA, Kodandaramaiah SB, Ogawa M, Ramanlal SB, Bandler RC, Allen BD, Forest CR, Chow BY, Han X, Lin Y, Tye KM, Roska B, Cardin JA, Boyden ES.

Nat Neurosci. 2014 Aug;17(8):1123-9. doi: 10.1038/nn.3752. Epub 2014 Jul 6.

14.

Optogenetic inhibition of chemically induced hypersynchronized bursting in mice.

Berglind F, Ledri M, Sørensen AT, Nikitidou L, Melis M, Bielefeld P, Kirik D, Deisseroth K, Andersson M, Kokaia M.

Neurobiol Dis. 2014 May;65:133-41. doi: 10.1016/j.nbd.2014.01.015. Epub 2014 Jan 31.

PMID:
24491965
15.

Novel approaches to epilepsy treatment.

Sørensen AT, Kokaia M.

Epilepsia. 2013 Jan;54(1):1-10. doi: 10.1111/epi.12000. Epub 2012 Oct 25. Review.

16.

Gene therapy of focal onset epilepsy using adeno-associated virus vector-mediated overexpression of neuropeptide Y.

Noe’ FM, Sørensen AT, Kokaia M, Vezzani A.

In: Noebels JL, Avoli M, Rogawski MA, Olsen RW, Delgado-Escueta AV, editors. Jasper's Basic Mechanisms of the Epilepsies [Internet]. 4th edition. Bethesda (MD): National Center for Biotechnology Information (US); 2012.

17.

Combined gene overexpression of neuropeptide Y and its receptor Y5 in the hippocampus suppresses seizures.

Gøtzsche CR, Nikitidou L, Sørensen AT, Olesen MV, Sørensen G, Christiansen SH, Ängehagen M, Woldbye DP, Kokaia M.

Neurobiol Dis. 2012 Jan;45(1):288-96. doi: 10.1016/j.nbd.2011.08.012. Epub 2011 Aug 22.

PMID:
21884793
18.

Functional integration of grafted neural stem cell-derived dopaminergic neurons monitored by optogenetics in an in vitro Parkinson model.

Tønnesen J, Parish CL, Sørensen AT, Andersson A, Lundberg C, Deisseroth K, Arenas E, Lindvall O, Kokaia M.

PLoS One. 2011 Mar 4;6(3):e17560. doi: 10.1371/journal.pone.0017560.

19.

The treatment of neurological diseases under a new light: the importance of optogenetics.

Kokaia M, Sørensen AT.

Drugs Today (Barc). 2011 Jan;47(1):53-62. doi: 10.1358/dot.2011.47.1.1543306. Review.

PMID:
21373649
20.

Activity-dependent long-term plasticity of afferent synapses on grafted stem/progenitor cell-derived neurons.

Sørensen AT, Rogelius N, Lundberg C, Kokaia M.

Exp Neurol. 2011 Jun;229(2):274-81. doi: 10.1016/j.expneurol.2011.02.008. Epub 2011 Feb 12.

PMID:
21324317
21.

Adeno-associated viral vector-induced overexpression of neuropeptide Y Y2 receptors in the hippocampus suppresses seizures.

Woldbye DP, Angehagen M, Gøtzsche CR, Elbrønd-Bek H, Sørensen AT, Christiansen SH, Olesen MV, Nikitidou L, Hansen TV, Kanter-Schlifke I, Kokaia M.

Brain. 2010 Sep;133(9):2778-88. doi: 10.1093/brain/awq219. Epub 2010 Aug 5.

PMID:
20688813
22.

Tuning afferent synapses of hippocampal interneurons by neuropeptide Y.

Ledri M, Sørensen AT, Erdelyi F, Szabo G, Kokaia M.

Hippocampus. 2011 Feb;21(2):198-211. doi: 10.1002/hipo.20740.

PMID:
20043282
23.

Optogenetic control of epileptiform activity.

Tønnesen J, Sørensen AT, Deisseroth K, Lundberg C, Kokaia M.

Proc Natl Acad Sci U S A. 2009 Jul 21;106(29):12162-7. doi: 10.1073/pnas.0901915106. Epub 2009 Jul 6.

24.

Hippocampal NPY gene transfer attenuates seizures without affecting epilepsy-induced impairment of LTP.

Sørensen AT, Nikitidou L, Ledri M, Lin EJ, During MJ, Kanter-Schlifke I, Kokaia M.

Exp Neurol. 2009 Feb;215(2):328-33. doi: 10.1016/j.expneurol.2008.10.015. Epub 2008 Nov 10.

25.

Activity-dependent volume transmission by transgene NPY attenuates glutamate release and LTP in the subiculum.

Sørensen AT, Kanter-Schlifke I, Lin EJ, During MJ, Kokaia M.

Mol Cell Neurosci. 2008 Oct;39(2):229-37. doi: 10.1016/j.mcn.2008.06.014. Epub 2008 Jul 3.

PMID:
18652899
26.

NPY gene transfer in the hippocampus attenuates synaptic plasticity and learning.

Sørensen AT, Kanter-Schlifke I, Carli M, Balducci C, Noe F, During MJ, Vezzani A, Kokaia M.

Hippocampus. 2008;18(6):564-74. doi: 10.1002/hipo.20415.

PMID:
18306304
27.

Wnt5a-treated midbrain neural stem cells improve dopamine cell replacement therapy in parkinsonian mice.

Parish CL, Castelo-Branco G, Rawal N, Tonnesen J, Sorensen AT, Salto C, Kokaia M, Lindvall O, Arenas E.

J Clin Invest. 2008 Jan;118(1):149-60.

28.

Social learning and health plan choice.

Sorensen AT.

Rand J Econ. 2006 Winter;37(4):1-29.

PMID:
17824132
29.

Information and consumer choice: the value of publicized health plan ratings.

Jin GZ, Sorensen AT.

J Health Econ. 2006 Mar;25(2):248-75. Epub 2005 Aug 16.

PMID:
16107284
30.

Differential suppression of seizures via Y2 and Y5 neuropeptide Y receptors.

Woldbye DP, Nanobashvili A, Sørensen AT, Husum H, Bolwig TG, Sørensen G, Ernfors P, Kokaia M.

Neurobiol Dis. 2005 Dec;20(3):760-72. Epub 2005 Jun 24.

PMID:
15979311
31.

Functional properties and synaptic integration of genetically labelled dopaminergic neurons in intrastriatal grafts.

Sørensen AT, Thompson L, Kirik D, Björklund A, Lindvall O, Kokaia M.

Eur J Neurosci. 2005 May;21(10):2793-9.

PMID:
15926926

Supplemental Content

Loading ...
Support Center